Joint Corp
NASDAQ:JYNT

Watchlist Manager
Joint Corp Logo
Joint Corp
NASDAQ:JYNT
Watchlist
Price: 8.98 USD -0.44% Market Closed
Market Cap: 133.5m USD

Wall Street
Price Targets

JYNT Price Targets Summary
Joint Corp

Wall Street analysts forecast JYNT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JYNT is 10.97 USD with a low forecast of 9.09 USD and a high forecast of 14.7 USD.

Lowest
Price Target
9.09 USD
1% Upside
Average
Price Target
10.97 USD
22% Upside
Highest
Price Target
14.7 USD
64% Upside
Joint Corp Competitors:
Price Targets
4004
Dallah Healthcare Company SJSC
9% Downside
THG
Thonburi Healthcare Group PCL
37% Downside
MIKA
Mitra Keluarga Karyasehat Tbk PT
27% Upside
BSL
Raffles Medical Group Ltd
19% Upside
IHH
IHH Healthcare Bhd
5% Upside
HCG
Healthcare Global Enterprises Ltd
14% Upside
ENSG
Ensign Group Inc
21% Upside
HCA
HCA Healthcare Inc
1% Upside

Revenue
Forecast

Revenue Estimate
Joint Corp

For the last 11 years the compound annual growth rate for Joint Corp's revenue is 22%. The projected CAGR for the next 3 years is 3%.

22%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Joint Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Joint Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JYNT's stock price target?
Price Target
10.97 USD

According to Wall Street analysts, the average 1-year price target for JYNT is 10.97 USD with a low forecast of 9.09 USD and a high forecast of 14.7 USD.

What is Joint Corp's Revenue forecast?
Projected CAGR
3%

For the last 11 years the compound annual growth rate for Joint Corp's revenue is 22%. The projected CAGR for the next 3 years is 3%.

Back to Top